Grants and Contributions:
Title:
Development of Novel Chemical Reagents for Commercialization to Cannabis Testing Labs
Agreement Number:
919344
Agreement Value:
$49,000.00
Agreement Date:
Jan 1, 2019 - Jun 30, 2019
Description:
Upon completion of the project, Rane will have new reagents that can be useful for the detection of cannabinoid active ingredients (THC/CBD) in the cannabis industry. This reagent can be used by non-technical persons to determine the potency of cannabis for recreational and medical purpose. This knowledge can be extended for the development of insecticides and pesticide in the agriculture and forestry field.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6E 5V2
Reference Number:
172-2018-2019-Q4-919344
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
737930321
Recipient Type:
For-profit organization
Recipient's Legal Name:
Rane Pharmaceutical Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541720